Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis

INTRODUCTION: Erythropoiesis-stimulating agents are associated with increased cardiovascular risk when higher doses are used toward higher hematocrit targets. Patients new to dialysis are at higher risk for morbidity and mortality. Systematic evaluation of this population was predefined in the roxad...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Kidney Int Rep
Auteurs principaux: Provenzano, Robert, Fishbane, Steven, Szczech, Lynda, Leong, Robert, Saikali, Khalil G., Zhong, Ming, Lee, Tyson T., Houser, Mark T., Frison, Lars, Houghton, John, Little, Dustin J., Peony Yu, Kin-Hung, Neff, Thomas B.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938204/
https://ncbi.nlm.nih.gov/pubmed/33732976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.12.018
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires